Institutions

Sievert Physical Therapy: The Clinic the DEA Linked to an Opioid Referral Network in the Upper Midwest

A DEA and DOJ investigation found that Sievert Physical Therapy participated in an opioid referral arrangement in which the clinic received payments tied to patient referrals for controlled substance prescriptions from connected prescribers.

A federal investigation led by the Drug Enforcement Administration and the Department of Justice identified Sievert Physical Therapy as a participant in an opioid prescription referral scheme operating in the upper Midwest — an arrangement in which the clinic received value for directing patients toward prescribers whose practices were focused on high-volume controlled substance prescribing, and in which the referral relationships were structured to generate payments not disclosed to patients or insurers.DOCUMENTED

The investigation was part of a broader enforcement sweep targeting the interconnected networks of prescribers, pharmacies, pain management operations, and ancillary healthcare providers that have facilitated high-volume opioid distribution in regions with concentrated opioid misuse problems. Physical therapy clinics occupy an unusual position in these networks: they see patients who are typically managing pain and who may be appropriate candidates for controlled substance prescriptions, making them a natural point of entry for referral schemes that channel patients toward high-prescribing physicians.

Key facts
  • Sievert Physical Therapy was linked to a DEA-investigated opioid referral network in the upper Midwest.
  • The clinic allegedly received payments tied to patient referrals for controlled substance prescriptions.
  • Referral payments were not disclosed to patients, insurers, or federal healthcare programs.
  • The scheme involved interconnected prescribers, pain management operators, and ancillary providers.
  • DEA investigations of this type typically proceed under the Controlled Substances Act and the Anti-Kickback Statute simultaneously.

The Anatomy of an Opioid Referral Scheme

Opioid diversion schemes involving referral payments typically involve at least three interconnected parties: a high-volume prescriber willing to issue controlled substance prescriptions with less clinical justification than standards require, a patient pipeline operated by clinics or brokers that can direct individuals seeking prescriptions to those prescribers, and a payment mechanism — often disguised as management fees, consulting arrangements, or lease payments — that transfers value from the prescribing side of the arrangement to the referral source.REVIEWED

Physical therapy clinics can function as patient pipeline operators because their patient populations are inherently self-selected for musculoskeletal pain — the conditions for which opioids are most commonly prescribed and most commonly diverted. A clinic that sees patients for knee, back, or shoulder injuries on a regular basis has consistent access to individuals who may be seeking or receptive to opioid prescriptions, and who are accustomed to receiving medical referrals through their existing care relationship. The DEA's investigation of Sievert Physical Therapy reflected the agency's focus on identifying and disrupting the referral network structures that enable high-volume controlled substance distribution beyond individual prescribers.DOCUMENTED

Legal Framework: Controlled Substances Act and Anti-Kickback Statute

Federal enforcement of opioid referral schemes typically involves parallel legal theories. The Controlled Substances Act makes it illegal to distribute or dispense controlled substances without a legitimate medical purpose and outside the ordinary course of professional practice — a standard that high-volume opioid prescribers in these arrangements routinely fail. The Anti-Kickback Statute applies to the referral side: any payment made to induce referrals of patients whose care may be covered by Medicare, Medicaid, or other federal healthcare programs is prohibited, regardless of how the payment is labeled in the parties' arrangement.REVIEWED

When both sets of violations occur together — an illegal prescriber receiving patient pipeline through a paid referral arrangement — the combined legal exposure is substantial. Criminal charges under the Controlled Substances Act can result in significant prison terms for prescribers. Civil liability under the False Claims Act applies to the clinic or other party receiving or paying the kickback when federal healthcare programs are involved. DEA administrative action can result in revocation of the prescriber's DEA registration, ending their ability to prescribe any controlled substance.DOCUMENTED

A physical therapy clinic that receives a referral fee every time a patient leaves for a pain clinic down the street is not running a billing error. It is running a pipeline.

The Upper Midwest Opioid Context

The investigation of Sievert Physical Therapy occurred against the backdrop of persistent opioid misuse problems in rural and small-city communities in the upper Midwest. While the initial phase of the opioid crisis was most concentrated in Appalachian and New England communities, the problem spread geographically over the following decade, with rural communities in states across the upper Midwest experiencing significant overdose rates and prescription drug misuse. Enforcement efforts in these regions have targeted not only individual prescribers but the networks that sustained high-volume prescribing by creating structured patient pipelines.REVIEWED

The DEA's regional approach to these investigations — identifying the referral network structure rather than simply prosecuting individual prescribers in isolation — reflects a strategic evolution in federal opioid enforcement. Early enforcement waves focused heavily on individual prescribers, but prosecutors found that network participants quickly adapted, finding new prescribers willing to fill the role of the removed actor. Disrupting the referral and payment mechanisms that sustain the network — including the clinics, brokers, and facilitators that channel patients toward high-prescribing physicians — is a more durable enforcement approach because it removes the infrastructure that any individual prescriber depends on.

What the Investigation Found at the Clinic Level

The DEA's investigation of Sievert Physical Therapy focused on the financial flows between the clinic and connected prescribers, and on records showing the correlation between payments received by the clinic and the volume of patients directed toward specific prescribers in the network. Physical therapy clinic records — appointment logs, referral documentation, billing records, and internal communications — provided the evidentiary basis for establishing both the referral pattern and the financial arrangement that sustained it. Digital records and financial institution records subpoenaed through the investigation provided additional corroboration of the payment flows.REVIEWED

For other physical therapy clinics and ancillary providers that receive payments from outside parties — particularly from pain management operations or prescribers — the Sievert investigation is a reminder that these arrangements are subject to Anti-Kickback Statute scrutiny regardless of how they are labeled. Management services agreements, space rental arrangements, and consulting fees paid by prescribers to clinics that refer patients to those prescribers will be evaluated based on the economic substance of the arrangement and its correlation to referral behavior, not on the legal category assigned to the payments in the parties' contracts.

Have documents relevant to this story? Reach us through our tips channel.

Every Watchdog Journal investigation is built on primary documents and classified under our evidence standard.

Browse All Investigations →